March 8, 2024
(press release)
–
dsm-firmenich today announced the successful sale and transfer of its 100% equity interest in DSM Jiangshan Pharmaceutical Co., Ltd. to Jingjiang Cosfocus Health Technology Co., Ltd. dsm-firmenich announced on June 28, 2023 it was exploring a range of options for the Jiangshan Vitamin C plant in Jinjiang, China. Financial details of the transaction were not disclosed. For more information, please contact: dsm-firmenich media enquiries: media@dsm-firmenich.com dsm-firmenich investor relations enquiries: investors@dsm-firmenich.com About dsm-firmenich: As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
